Researchers estimate that more than 80 million U.S. adults are living with obstructive sleep apnea, a condition in which the ...
Randomized trials of positive airway pressure therapy for obstructive sleep apnea have not shown a significant difference in ...
U.S. Air Force Capt. Emily Lee (right), 59th Medical Wing audiologist, demonstrates Tympanometry, a procedure to diagnose issues with the middle ear, on fellow Audiologist Capt. Jacqueline Anderson at ...
A promising new drug could put an end to cumbersome CPAP machines and allow millions of Americans to breathe easy and sleep soundly. Researchers at the biopharm company Apnimed have been developing a ...
Wearables like the Apple Watch and Oura Smart Ring often have substantial positive impacts on the health and fitness of their wearers thanks to providing detailed information and encouraging healthy ...
A vibrating device may help some patients with a form of obstructive sleep apnea (OSA), even after stopping use, according to a new study presented at the American Thoracic Society (ATS) 2026 ...
May 18 (Reuters) - Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main goal in a late-stage trial, potentially offering a convenient alternative ...
A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ATS International Conference. The drug, called AD109, is the first therapy to ...
Annual medical checkups typically cover the basics: diet, exercise and mental state. Surprisingly, many primary care providers fail to ask about one of the fundamental contributors to well-being: ...
Klar Yaggi was first drawn to sleep medicine for the mystery. “It’s still a very young field with a lot of interesting questions that remain to be asked and answered,” said Yaggi, professor of ...
There are at least a dozen reasons why women may wake up with a headache, jitter with anxiety, or struggle to keep their eyes open at work, no matter how well they think they slept: menstruation, ...
Shionogi has struck a deal to take full control of its sleep disorder joint venture, agreeing to pay Apnimed $100 million upfront for its partner’s half of the business. Shionogi called the joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results